Former Pfizer Senior Corporate Counsel Joins Nutter
Nutter Expands Its Biotech/Pharma Intellectual Property Practice With the Addition of Konstantin Linnik
(firmenpresse) - BOSTON, MA -- (Marketwire) -- 12/05/11 -- The law firm of announced that , Ph.D., has joined the firm as a partner in the He will use his extensive industry expertise to benefit biotechnology, pharmaceutical, and medical device clients and support their innovation goals. His work will focus on IP strategy; competitive analysis; patent portfolio development, licensing, enforcement and patent litigation. Before joining Nutter, Linnik was senior corporate counsel at , the world's largest pharmaceutical company, where he was lead patent counsel for Pfizer research units in the US, Canada, and Germany.
"Coming from an industry leader, Konstantin offers our clients the immediate experience and insights into the intellectual property issues faced by major pharmaceutical companies," said , co-managing partner of Nutter. "Adding Konstantin expands the biotech and pharma depth of our intellectual property team. This addition is part of our overall strategy to bring experienced and innovative legal counsel to pharma and biotech companies that are looking to maximize the opportunities that come with intellectual property."
Before joining Pfizer, Linnik represented a number of biotechnology and pharmaceutical companies as external counsel. Aside from his legal training, Linnik earned a Ph.D. in cell biology from Boston University School of Medicine. Linnik is active in the Boston legal community and currently chairs the Biotechnology Committee of the Boston Patent Law Association.
Nutter McClennen & Fish LLP represents an international roster of innovative clients involved in a range of sophisticated technologies in the medical device, biotechnology and pharmaceutical industries, as well as renowned medical institutions and research universities, emerging growth companies and angel and venture capital firms. The firm's expertise spans IP strategy, prosecution and litigation; strategic collaborations and licensing; clinical trials and regulatory compliance; as well as M&A, capital raising and finance, government investigations and defense, and product liability. Nutter was co-founded in 1879 by Louis D. Brandeis, who later became one of the most celebrated justices of the U.S. Supreme Court in modern times.
Lisa Jentzen
617-439-2894
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 05.12.2011 - 16:01 Uhr
Sprache: Deutsch
News-ID 94043
Anzahl Zeichen: 0
contact information:
Town:
BOSTON, MA
Kategorie:
Biotech
Diese Pressemitteilung wurde bisher 252 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Former Pfizer Senior Corporate Counsel Joins Nutter"
steht unter der journalistisch-redaktionellen Verantwortung von
Nutter McClennen & Fish LLP (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
